Dror Bashan | President, Chief Executive Officer |
Eyal Rubin | Senior Vice President, Chief Financial Officer |
Monique Kosse | LifeSci Advisors |
Boobalan Pachaiyappan | HC Wainwright |
John Vandermosten | Zacks Small Cap Research |
Good morning ladies and gentlemen and welcome to the Protalix full year 2022 earnings call.
As a reminder, this conference is being recorded.
I will now turn the conference over to your host, Monique Kosse of LifeSci Advisors, investor relations for Protalix. Thank you, you may begin.
Thank you Operator, and welcome to the Protalix BioTherapeutics’ fiscal year 2022 financial results and business update conference call.